13-Apr-2009
Entry into a Material Definitive Agreement
Item 1.01 Entry Into a Material Definitive Agreement.
On April 7, 2009, Abraxis BioScience, LLC ("Abraxis"), the wholly-owned operating subsidiary of Abraxis BioScience, Inc., entered into an agreement of purchase and sale and joint escrow instructions (the "Agreement") with 3300 Hyland I, LLC, a Delaware limited liability company ("Seller"), under which Abraxis agreed to purchase certain real property located at 3300 Hyland Avenue in Costa Mesa, California for an aggregate purchase price of $30.5 million, including $1 million which has been deposited into escrow. The acquisition will include a 15 acre site with an approximately 180,000 square foot three-story building, including approximately 70,000 square feet of laboratory space. Consummation of the transaction is subject to customary closing conditions, including delivery of satisfactory title.
http://biz.yahoo.com/e/090413/abii8-k.html
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM